The OSI Announces 2022 Grant Recipients

A leading funder of osteosarcoma research awards a total of $1 million to two groundbreaking research projects.

The Osteosarcoma Institute (OSI) — a leading funder of osteosarcoma research — is pleased to announce its 2022 research grant funding recipients. Out of 25 applications submitted in the 2021-2022 grant cycle, the OSI’s expert review committee selected two potentially groundbreaking scientific research projects.

“This year, we selected two novel research studies to receive $500,000 each,” says Lee Helman, MD, the OSI’s Director and an expert in the field of osteosarcoma. Since its inception in 2017, the OSI has awarded more than $5 million to cutting-edge osteosarcoma research. Funding research is an early step toward developing better treatments, and ultimately, a cure. The standard treatments for osteosarcoma have not changed in 40 years. New kinds of therapies are critical to saving lives.

[et_pb_acf_single_item field_name=”Posts|image_gallery” image_size=”et-pb-image–responsive–phone” admin_label=”First Gallery” module_class=”first-gallery” _builder_version=”4.17.4″ _module_preset=”default” display_conditions=”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” global_colors_info=”{}”][/et_pb_acf_single_item][et_pb_acf_single_item field_name=”Posts|gallery_texts” image_size=”et-pb-image–responsive–phone” admin_label=”First Gallery” module_class=”first-gallery” _builder_version=”4.17.4″ _module_preset=”default” text_font=”Open Sans|600|on||||||” text_text_color=”#000000″ text_font_size=”13px” display_conditions=”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” global_colors_info=”{}”][/et_pb_acf_single_item][et_pb_acf_single_item field_name=”Posts|2nd_content” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#000000″ text_line_height=”25px” headings_font=”Brandon Grotesque Bold||||||||” headings_font_size=”26px” display_conditions=”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” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_acf_single_item]

“These are two promising studies that are led by exemplary scientists. I am eager and excited to see what data unfolds.” — Lee Helman, MD, OSI’s Director

[et_pb_acf_single_item field_name=”Posts|4th_content” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#000000″ headings_font=”Brandon Grotesque Bold||||||||” headings_font_size=”26px” display_conditions=”W10=” global_colors_info=”{}”][/et_pb_acf_single_item]